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Summary The proliferation rate of vascular endothelium has been studied using repeated administrations of
tritiated thymidine, given every 8 h for 1 week. Five experimental mouse tumours have been investigated and
compared with placenta and with normal tissues. The large difference in labelling indices between tumour and
normal endothelium that has previously been detected with single injections of ([3H]dT) is confirmed by these
continuous labelling studies. The potential doubling time of the tumour endothelium is estimated to be
between 2.4 and 13 days for the five tumours. Tpot for the placenta is at least as short. The turnover time of
the normal tissue endothelium is estimated to be 20-2000 times longer (47-23,000 days) and does not seem to
differ in slow turnover tissues e.g. lung and liver from that in tissues where the parenchymal cells are rapidly
turning over e.g. jejunum or skin.
Most normal tissues in the adult have a low rate of
cell turnover, with the notable exception of the
epithelial tissues and the haemopoietic elements in
the bone marrow. The stromal supporting tissue,
which is common to all organs, has an extremely
slow turnover. In particular, the smooth muscle and
endothelial cells of the blood vessel have a turnover
time of many months (Hirst et al., 1980). For this
reason several authors have suggested that blood
vessels are the common target for all late radiation
injury, and are the common pathway leading to the
parenchymal cell death which occurs months to
years after irradiation, e.g. in lung, kidney, spinal
cord (Rubin & Casarett, 1968; Hopewell, 1974; van
der Kogel & Barendsen, 1974). However this is not
universally accepted.
It is well known that tumours can evoke a more
rapid proliferation of the blood vessel components.
Most solid tumours induce the formation of new
thin-walled capillaries and sinusoids, although some
tumours, especially lymphomas, can obtain much of
their nutrient supply by invasion and utilization of
existing vessels (Denekamp & Hobson, 1982). The
budding and proliferation of new blood vessels is
believed to result from tumour angiogenesis factors
(TAF) which are produced by tumour cells
(Folkman et al., 1971). Relatively few quantitative
studies have been made of the proliferation rate of
tumour endothelium (Tannock, 1970; Gunduz,
1981; Hirst et al., 1982; Denekamp & Hobson,
1982), but it has recently been shown that there is a
30-40 fold greater proliferation rate in the
endothelium of blood vessels in tumours than in
normal vessels (Denekamp, 1982; Denekamp &
Hobson, 1982).
The present study was undertaken to see if the
same conclusion would be obtained from
continuous infusion of tritiated thymidine as that
from single pulse injections of the label. By this
means the statistical significance of the data can be
improved (as more labelled cells will be available
for counting) and any artefact due to diurnal
variations in thymidine uptake will be avoided.
Materials and methods
Five types of mouse mammary carcinoma that
arose spontaneously in our inbred CBA/Ht or WHt
strains of mice were used for these experiments.
One of the tumours (Ca RH) arose in 1966 and has
been serially transplanted for -35 generations.
This was the slowest growing of the tumours and
has previously been used in radiobiological and cell
kinetic studies (Hewitt et al., 1976; Denekamp &
Stewart, 1978; Hirst & Denekamp, 1979; Hill &
Denekamp, 1979; Denekamp et al., 1980;
Denekamp & Hobson, 1982). The other 4 types of
tumour arose more recently. They are maintained
in a frozen bank and have only been serially
transplanted for between four and eleven
generations. These tumours were chosen because
they had a well defined and readily recognisable
vasculature in histological sections. Some of the
tumour characteristics are listed in Table I. The
tumours were transplanted s.c. on the dorsum of
the mouse, using small fragments (_ mm3)
implanted with a trochar under penthrane
anaesthesia. Two tumours were transplanted into
each mouse. The tumours were observed regularly
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Table I Mouse tumour characteristics
Volume
Mouse Tumour Passage doubling time
Tumour strain origin number (days)
CA TB CBA/Ht 1980, axilla
carcinoma 4 2.2
CA AD CBA/Ht 1979, thorax
carcinoma 11 2.4
CA BAC CBA/Ht 1980, thorax
adenocarcinoma 8 3.3
CA HAL WHt 1979, thorax
adenocarcinoma 5 11.1
CA RH WHt 1966, thorax
adenocarcinoma 35 13.3
and measured 2-3 times a week after they became
palpable. When they reached the desired size range
the mice were selected for thymidine
administration. Two size ranges were chosen for
study: a mean diameter of 3.5-5.Omm and of 7.0-
8.0 mm, correponding to a 6-fold increase in
volume.
Tritiated thymidine ([3H]dT) was obtained from
Amersham International at a specific activity of
2CimM-1 and at a concentration of 1 mCiml-1.
This was diluted to 1mCi 10ml-1 in saline and
each animal received 15-20pCi per injection,
according to its weight (i.e. -0.5pCig-1). Mice
were injected i.p. every 8+0.5h for up to 7 days.
Two mice were sacrificed at each chosen time
interval and the tumours and normal tissues of
interest were removed and fixed in 10% buffered
formol saline. A group of pregnant females was
also included in the study, in order to compare the
proliferation rate in the placenta with that in the 5
tumours. These mice were in the tenth day of
gestation at the beginning of the experiment.
All samples were processed, embedded in wax
and sectioned at 4 pm. They were dipped in Ilford
K5 nuclear emulsion and exposed in the dark-room
for 4-6 weeks at 4°C. The resulting auto-
radiographs were developed, fixed and stained
with haematoxylin and eosin. Labelled cells were
counted under high magnification ( x 500 - x 1250).
The endothelial cells were identified as flattened,
elongated cells lining spaces which contained
erythrocytes. Thus lymphatic vessels were excluded,
but small capillaries or vessels from which the
blood had been lost in processing were also missed.
An attempt was made to count at least 1,000 cells
for each time point, but it was not always possible
to identify enough endothelial cells. The total
counts ranged from 450 to 5,300 per time point for
normal tissues and from 310 to 2,200 for tumours.
For the normal tissues 2 animals and for the
tumours 1-4 animals were counted for each time
point. A cell was considered labelled if there were
at least 3 grains above background. In practice
most labelled cells had more than 10 grains and the
background was usually less than 1 grain per cell-
sized area.
Results
The labelling indices (labelled endothelial cells per
100 endothelial cells) obtained 1 h after a single
injection of tritiated thymidine are listed in Table
II. In the tumours the values ranged from 3-14%.
This is in good agreement with previous studies
(Denekamp & Hobson, 1982). By contrast the
labelling index was very low in all the normal
tissues, except placenta where it was 12.7%. The
values ranged from 0.04% in muscle and brain to
0.67% in lung and liver. These are also in good
agreement with other published data (see Hirst et
al., 1980 for summary).
The results of the continuous labelling, by
repeated 8-hourly injections, are summarised in
Figures 1-4. The labelling index in the 5 tumours
rose rapidly with increasing time of exposure to
([3H]dT). There was little difference in values for
small or large tumours (Figures 1 & 2). By 3 days
approximately half of the endothelial cells were
labelled, and by 7 days this had reached almost
100% in CA AD (Figures 1 & 2, Table II). The
uptake in the other four tumours plateaued beyond
2-6 days. These data show that the blood vessels in
tumours have a rapid rate of proliferation; the
vascular network has the potential to double in
volume in approximately one week.
The normal tissue data are summarised in Figure
3. Endothelial cells were counted at random, but in
some normal tissues it was not possible using light
microscopy to distinguish capillary endothelial cells
from other cell types. These areas (alveolar walls in
lung, glomeruli in kidney and sinusoids in liver)
were avoided in the counting. The data for normal
tissues contrast sharply with those for tumours
(note the expanded vertical scale). After 3 days of
labelling <2% of the endothelial cells were labelled
in most normal tissues, increasing to only -3% by
1 week. The liver showed a somewhat higher
labelling index and reached about 10% after 7 days
(Figure 3, Table II).
A limited analysis of the proliferative index in
vessels of different calibre was attempted. It proved
extremely difficult and was therefore curtailed. The
pooled data obtained from all normal tissues
assessed in this way are given in Table III.
The results from the placenta are shown in
Figure 4. There is a large scatter in the first 2-3ENDOTHELIUM: CONTINUOUS LABELLING STUDIES 407
Table II Turnover times for endothelial cells
Jh 7day 3day
Tissue LI(%) Tp'ta LI(%) Tpt,b LI(%) Tp.tc
CA AD 14.1 2.4 92.7 8.1 58.1 6.3
CA TB 10.2 3.3 70 11.0 48.1 7.6
CA HAL 3.4 10.0 - 33.3 10.1
CA RH 6.6 5.1 63.7 11.9 36.6 9.8
CA BAC 9.0 3.8 60.8 12.8 52.7 6.7
Placenta 12.7 2.7 - 79.5d 4.4
Brain 0.04 794 <0.16 5832 0.8 395
Muscle 0.04 794 0.8 921 0.5 652
Jejunum <0.23 138 <0.3 9977 1.2 309
Skin <0.34 93 <0.37 23254 1.1 394
Heart 0.33 96 3.2 244 1.8 204
Kidney 0.39 81 2.7 302 2.05 180
Lung 0.67 47 2.8 327 1.75 276
Liver 0.67 47 9.3 81 4.4 80
Bladdere <0.2 159 3.0 250 1.5 231
Mesenteryf 0.45 71 0.8 1991 0.3 299
aTpot =ATs/LI with Ts= 11 h and A=0.693 for normal
tissues and =0.74 for tumours and placenta.
bFrom extrapolation through 1 h and 7 day labelling
indices, using eq. 2 in text.
cFrom extrapolation through 1 h and 3 day labelling
indices, using eq. 3 in text.
dUsing 48h value because 72h value is anomalously
low.
eData from Stewart et al., 1980.
fData from Hirst et al., 1980.
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Figure 1 Continuous labelling of endothelium in S types of experimental tumour. Tritiated thymidine was
injected i.p. every 8h, beginning when the tumours measured 3.5-5.0mm mean diameter. Each point
represents a separate animal.
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Figure 2 Continuous labelling of endothelium in larger experimental tumours, measuring 7-8mm mean
diameter at the time of the first injection. ([3H]dT) was administered i.p. every 8h.
Table III Endothelial proliferation in different types of vessels
Arteries & Veins &
arterioles venules Capillaries
3 36 29
Present data -=030% 10=3.0% 51 =0.60% 1162 1207 5197
Spaet & Lejneiks 28 27 0 064
(1967) 2,0 =0.13%a 730 =0.37 0 160060
Compilation of 45 289
b ~~~~ = 0.45% ~~~=0.1100 published datab 1000=0.45% - 239,567 %
aIncludes estimates for aorta derived from count per field x number of
fields x number of sections.
bData from: Engerman (1967) Gaynor (1971)
Hirst et al. (1980) Stewart et al. (1980)
Tannock & Hayashi (1972)
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Figure 3 Uptake of tritiated thymidine into the endothelial cells of eight normal tissues, when administered
by repeated i.p. injection every 8h. Note the expanded vertical scale and the very low uptake. All 8 tissues
show a slow rate ofendothelial proliferation.
days. These data are grossly different from those
for the other normal tissues and actually show a
more rapid uptake of tritiated thymidine than any
of the tumours studied. All of the endothelial cells
were labelled within 4 days. This indicates that
endothelial proliferation can occur even more
rapidly in placenta than in transplanted tumours.
We also measured the endothelial labelling index
in a selection of slides of human tumours and it
was found to fall within the same range as that
measured for rodent tumours. A short exposure of
biopsy specimens to ([3H]dT) in vitro resulted in
2.8-4.6% of the endothelium being labelled in
assorted lymphomas and epithelial tumours
(provided by Dr. J. Kummermehr). After
administration of ([3H]dT) in vivo, 4.2-8.1% of
endothelial cells were labelled in a human
glioblastoma (provided by Dr. T. Hoshino) and 10-
20% in a human parotid tumour (provided by Dr.
C. Nervi).
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Figure 4 Uptake of tritiated thymidine into the placenta when administered i.p. every 8h from the 10th day
of gestation. There is considerable scatter at the early intervals but endothelial proliferation is obviously
rapid.
Discussion
These data confirm our earlier finding of a large
and consistent difference between the proliferation
rate of endothelium in normal and tumour blood
vessels (Denekamp, 1982; Denekamp & Hobson,
1982). The initial labelling indices 1 h after a pulse
label differ on average by a factor of 26, and this
large difference persists after continuous labelling
for periods up to 7 days. The normal tissue values
at 1 h ranged from 0.04-0.67% (brain and muscle
versus liver); it was difficult to be certain of the
statistical significance of these differences because
of the small number of labelled cells. However, the
same order of difference is apparent after 7 days
labelling, when the brain still shows very little
uptake of ([3H]dT), whereas in the liver - 10% of
the endothelial cells are labelled (Table II). Because
of its function as a detoxifying organ the liver
endothelium is exposed to a high concentration of
potentially toxic metabolites. Furthermore, part of
the afferent supply of blood is through the portal
vein and is relatively poorly oxygenated. These
factors may combine to lead to a more rapid death
and replacement of endothelial cells in the liver
blood vessels. In addition it is difficult to be
absolutely sure that no Kupffer cells were included
in the counts, although liver sinusoids were
generally avoided.
The labelling in the five types of tumour is of a
different order of magnitude. No significant
differences were seen in small (3-5mm) tumours
compared with large tumours (Figures 1 & 2). The
initial LI values of 3-14% rose rapidly for the first
2-3 days and then for some tumours more slowly
over the remaining 4 days of the study. This change
in rate of uptake of tritiated thymidine in 4/5
tumours suggests that not all of the endothelial cells
in the tumour vessels are actively involved in
proliferation. The change in slope at 30% and
50% labelling could be interpreted as a growth
fraction of 30 and 50% in these tumours (Steel et
al., 1966). However, it is not possible to deduce
from these data whether 50-70% of the cells in
each vessel are quiescent, or whether proliferation
has completely ceased in this proportion of the
vessels within each tumour. It seems more likely
that the latter would be true: more active
endothelial proliferation might occur in the vessels
nearest to the outer rim of the tumour, since the
tumour is expanding radially from the centre and
the nutritional quality of the blood in deeper vessels
is likely to be poor. An elevated labelling index has
been reported for the rim of liver metastases, once
12D
-!rl-PF-, 4w;& i!..4'' I. =- # p 1 :6- ..
.. .. -., 77- -W ..r. .1
- T MILIMME- WI"
..%..;,.,. f.-.
I..:
.-i,IENDOTHELIUM: CONTINUOUS LABELLING STUDIES 411
they exceed 1 mm in diameter (Bassermann &
Rabes, 1983). These authors also observed
increased proliferation of the sinus endothelium in
the immediately adjacent normal liver.
The labelling in the placenta increased most
rapidly with continuous labelling over the first 48h.
There is a large spread of values from one animal
to another for this tissue over this early period.
This is consistent with other reports of large
variations in ([3H]dT) uptake in foetal and
placental tissue, even for adjacent foetuses in the
same mother (Atlas et al., 1960). In spite of the
scatter it is obvious that endothelial proliferation in
the placenta is even more rapid than that in any of
the five experimental tumours in the present study.
These labelling data can be used in several ways
to estimate the potential doubling time (Tpot) of the
endothelium. In order to calculate this parameter a
value for the DNA synthesis phase Ts has to be
used. Korr et al. (1975) used a double labelling
technique for endothelial cells in normal brain and
derived an estimate of 11.0+2.2h for Ts. In
principle the continuous labelling data in Figures 1-
4 can also be used to estimate Ts for each tumour
and tissue (Yamada & Puck, 1961), but this gives
an enormous spread of Ts values (7h-oo). Korr's
measured value of Ts= 11 h for endothelial cells in
brain capillaries has therefore been adopted for the
following calculations. Steel (1968) showed that
Tpot could be calculated for an expanding
population from the initial labelling index after a
single injection, using the formula
Tpot = i LI (1)
where A is a factor which corrects for the non linear
age distributions of cells around the cell cycle. A
value of 0.693 for A seems appropriate for cells with
a long cell cycle time, or a large fraction in Go; this
value has therefore been adopted for normal tissues,
and A=0.74 for the 5 tumours and the placenta
(Steel, 1977).
If all the cells in the population are in the growth
fraction, the labelling index should reach 100% in a
time corresponding to the potential doubling time
minus Ts. This can be derived from the LIlh and
LI7day values as follows:
pot -s=OO%-LIlhx7 days (2) L17d-LIlh
If only a proportion of the cells are in the growth
fraction and these supply cells to the non-
proliferating compartment there would be an initial
rapid increase in LI until all the cells in the growth
fraction have taken up label, and then a slower
increase as the labelled cells gradually dilute out the
non-dividing subpopulation. (Steel et al., 1968).
Thus, the very shallow slope for the normal tissues
may result from a very small growth fraction of 1-
2%, as has been suggested by Korr et al., (1975)
and Hirst et al. (1980). Therefore a third estimate
of Tpot has been made using the data at an earlier
interval i.e. 2-3 days (Table II)
Tpot-Ts=LIOO%-LIlh X 3 days LI3d-LIlh (3)
The estimates from this latter equation are
generally shorter than those from eq. (2), because
they are derived from the initial steeper increase in
labelling.
All these estimates of Tpot are listed in Table II
and are summarised in Figure 5. Two other
published normal tissues studied at the Gray
Laboratory have been included for comparison:
bladder endothelium (Stewart et al., 1980) and
mesenteric arterioles (Hirst et al., 1980). There is a
considerable variation in the estimates of Tpot from
the three equations. However, there is clearly a very
large difference between the normal adult tissues on
the one hand and the placenta and tumours on the
other (note the vertical axis in Figure 5 is on a
logarithmic scale).
Among the unstimulated normal tissues the liver
shows the shortest turnover time and the brain the
longest. Within each tissue there may also be subtle
differences in vessels of different calibre. In a
limited analysis of veins, arteries and capillaries of
normal tissues we observed the highest proliferation
index in the veins (Table III). This is somewhat
surprising in view of the hypothesis that endothelial
cell turnover is most marked in regions of highest
turbulence (Payling Wright, 1968), since flow is
more rapid and pulsatile in arteries than in veins.
However the endothelial cells in veins are probably
subject to more stretch since the vessel diameter can
vary more because of their less rigid wall structure.
There is only one study in the literature where a
systematic investigation of vessels of different
calibre has been made (Spaet & Lejneiks, 1967).
Their data indicated very little difference in
different vessels, but the highest uptake of ([3H]dT)
occurred in capillaries (Table III). A review of all
the other published data, sub-divided into different
vessel types, is included in Table III. Most of the
studies are stated to be of capillaries, in which
almost a quarter of a million cells have been
assessed. From this compilation of data the highest
labelling index occurs in arteries and arterioles.
Table III shows that no consistent picture emerges
as to which type of vessels have the highest
labelling index. This point is worthy of further
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Figure 5 Turnover times calculated from labelling indices (0) from Tpot=TS/LIlh; (U) using 1 h and 3 day
labelling indices; (A) using 1 h and 7 day labelling indices.
Data from Figures 14, and 36 values for I h LI from Gunduz (1981), 10 values from Tannock (1970 and
pers. comm.), 13 values from Denekamp & Hobson (1982) for tumours, plus data from Hirst et al., (1980) for
mesentery and Stewart et al., (1980) for bladder. Nine human tumours were counted (by B.H.) from slides
provided by Drs. Nervi, Kummermehr & Hoshino.
The high uptake of thymidine into the placenta
indicates that if it is subject to an appropriate
stimulus the endothelium is capable of even more
rapid proliferation than that which occurs in the
animal tumours we tested. Tumour angiogenesis
factors have a large effect on the direction of
capillary budding and endothelial cell migration,
perhaps with increased endothelial cell proliferation
as a secondary consequence (Folkman, 1983;
Kumar, 1983). Capillaries within tumours, however,
are surrounded on all sides by the angiogenic
stimulus and may therefore be less profoundly
influenced by TAF than vessels stimulated uni-
laterally in the model systems used to study TAF.
The present studies confirm the large difference
previously reported between tumour and normal
blood vessels, but with more statistical accuracy
because of the continuous labelling. This provides a
quantitative basis to the general observation of
increased angiogenesis in tumours. The
comprehensive study of tumour vascular
proliferation in lung metastases by Gunduz (1981)
showed an even higher labelling index than those
reported here. Over a wide range of tumour sizes he
found LI 1 h= 14% and he also saw a dramatic
increase in LI with repeated injections. His data
differed by a factor of 100 from those for normal
tissues reported by Gaynor (1971), despite the
statement to the contrary in his paper.
These data confirm that there is a sound basis
for continuing to seek methods of attacking
proliferating endothelium as a means of targeting
cytotoxic treatment to tumours (Denekamp, 1982;
Denekamp & Hobson, 1982).
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